Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) Research & Development (2023 - 2026)

BioAge Labs' Research & Development history spans 2 years, with the latest figure at $24.5 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 27.44% to $24.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $74.0 million, a 25.29% increase, with the full-year FY2025 number at $74.0 million, up 25.29% from a year prior.
  • Research & Development hit $24.5 million in Q4 2025 for BioAge Labs, up from $18.5 million in the prior quarter.
  • Over the last five years, Research & Development for BIOA hit a ceiling of $24.5 million in Q4 2025 and a floor of $9.3 million in Q1 2024.